RealTalk MS Episode 28: Pediatric MS With Dr. Emmanuelle Waubant

When we think about MS, we tend to think about it as an adult disease. But the National MS Society reminds us that between 8,000 and 10,000 children up to 18 years old are living with MS in the United States. And studies suggest that between 2 and 5% of everyone living with MS has a history of experiencing the onset of at least one MS symptom before the age of 18.

My guest on the podcast is Dr. Emmanuelle Waubant, one of the true pioneers and recognized experts in the field of pediatric MS. We're talking with Dr. Waubant about some of the challenges involved in diagnosing pediatric MS, which disease-modifying therapies can be used to treat pediatric MS (since the FDA hasn't specifically approved any drug to treat pediatric MS) and how kids living with MS deal with all of the regular growing up challenges that life throws at them.

____________

Healthcare Spending Doubles For People Living With MS 3:38

Vocal Biomarker Detects MS By the Sound of Your Voice 6:44

Researchers Will Study Quality of MS Care in the U.S. 8:11

2018 Dystel Prize for MS Research To Be Awarded 9:33

Interview with Dr. Emmanuelle Waubant 11:24

___________

LINKS
If your podcast app doesn't show these links, you'll find them in the show notes at www.RealTalkMS.com

Healthcare Spending Doubles for People Living With MS

Sonde Health Patents Vocal Biomarker Technology

Study Looks At Quality of MS Care

Dystel Prize For MS Research Awarded to Dr. Frederik Barkhof

___________

Follow RealTalk MS on Twitter, @RealTalkMS_jon, and subscribe to our newsletter at our website, RealTalkMS.com.

RealTalk MS Episode 28
Guest: Dr. Emmanuelle Waubant
Hosted By: Jon Strum

Tags: MS, multiple sclerosis, pediatric MS, MS patient costs, Sonde Health, vocal biomarker, Dartmouth Medical Center, MS Care, Dystel Prize, Dr. Frederik Barkhof